Make Kitco Your Homepage

Exclusive: Trump, Pfizer CEO Ian Read spoke about drug pricing - source

Kitco News

NEW YORK/WASHINGTON (Reuters) - U.S. President Donald Trump called Pfizer Chief Executive Ian Read on Tuesday and discussed the company’s July 1 price hikes for 10 to 15 minutes, communicating that the increases had complicated the administration’s drug pricing plans, according to a source familiar with the matter.

Pfizer said on Tuesday it was deferring its drug price increases on around 40 drugs for no more than six months after Read’s conversation with Trump.

Reporting by Michael Erman and Yasmeen Abutaleb; Editing by Nick Zieminski

Disclaimer: The views expressed in this article are those of the author and may not reflect those of Kitco Metals Inc. The author has made every effort to ensure accuracy of information provided; however, neither Kitco Metals Inc. nor the author can guarantee such accuracy. This article is strictly for informational purposes only. It is not a solicitation to make any exchange in commodities, securities or other financial instruments. Kitco Metals Inc. and the author of this article do not accept culpability for losses and/ or damages arising from the use of this publication.

Precious Metal Charts

Follow Kitco News

MintFirst Britannia's